Skip to main content
Top
Literature
1.
go back to reference Cara AKS, Zaidi STR, Suleman F. Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia. Int J Clin Pharm. 2018;40(5):1051–8.CrossRefPubMed Cara AKS, Zaidi STR, Suleman F. Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia. Int J Clin Pharm. 2018;40(5):1051–8.CrossRefPubMed
2.
go back to reference Kalin G, Alp E, Coskun R, Demiraslan H, Gündogan K, Doganay M. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? J Infect Chemother. 2012;18(6):872–7.CrossRefPubMed Kalin G, Alp E, Coskun R, Demiraslan H, Gündogan K, Doganay M. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment? J Infect Chemother. 2012;18(6):872–7.CrossRefPubMed
3.
go back to reference Zaidi STR, Al Omran S, Al Aithan ASM, Al Sultan M. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. J Clin Pharm Ther. 2014;39(3):272–6.CrossRefPubMed Zaidi STR, Al Omran S, Al Aithan ASM, Al Sultan M. Efficacy and safety of low-dose colistin in the treatment for infections caused by multidrug-resistant gram-negative bacteria. J Clin Pharm Ther. 2014;39(3):272–6.CrossRefPubMed
4.
go back to reference Musher DM. Clinical and microbiological end points in the treatment of pneumonia. Clin Infect Dis. 2008;47(Supplement_3):S207–9.CrossRefPubMed Musher DM. Clinical and microbiological end points in the treatment of pneumonia. Clin Infect Dis. 2008;47(Supplement_3):S207–9.CrossRefPubMed
Metadata
Title
Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia: a comment
Authors
Effat Davoudi-Monfared
Maryam Taghizadeh-Ghehi
Publication date
01-06-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00822-6

Other articles of this Issue 3/2019

International Journal of Clinical Pharmacy 3/2019 Go to the issue